STENOCARE Begins Sales of New CBD100 Oil Product in Denmark

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER:  STENO

STENOCARE A/S (“Stenocare”) has delivered the first shipment of its new CBD100 Oil product to the Danish market. With this new medical cannabis oil product, Stenocare now offers four different prescription-based medical cannabis oil products to Danish patients, making it the leading provider of oil products in the Danish Pilot Programme

Since 2018, Stenocare has been a leading supplier of prescription-based medical cannabis oil products in the Danish Pilot Programme. The company already offers a THC30 Oil product, a CBD20 Oil product, and a THC/CBD Oil product. Now, Stenocare is adding its CBD100 Oil product to the portfolio—providing patients with even more treatment options and further strengthening its position as a leading provider of medical cannabis oil products in the Pilot Programme.

The new product is named CBD100 Oil Stenocare, and it contains 100 mg/ml CBD and 5 mg/ml THC in a 30 ml bottle. The first shipment of CBD100 has just been delivered in Denmark and is now available to patients across the country.

Sign-up for Stenocare news here: https://stenocare.com/subscribe-for-newsletter/ to automatically receive the latest news and information about the company.